Newton Center, MA, United States of America

Vijay K Kuchroo

USPTO Granted Patents = 33 (Patent Applications = 38)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 10)

Average Co-Inventor Count = 4.3

ph-index = 8

Forward Citations = 345(Granted Patents)

Location History:

Newton Center, MA (US) (2012 - 2018)
Newton, MA (US) (2001 - 2021)
Chestnut Hill, MA (US) (2021)
Boston, MA (US) (2009 - 2024)

Company Filing History:

32 out of 1,370

The Brigham and Women's Hospital, Inc.

patents

15 out of 443

The Broad Institute, Inc.

patents

15 out of 8,369

Massachusetts Institute of Technology

patents

4. 8 out of 1,206

Dana-farber-cancer Institute Inc.

patents

5. 3 out of 516

Beth Israel Deaconess Medical Center, Inc.

Leland Stanford Junior University

patents

8. 1 out of 15,458

University of California

The General Hospital Corporation

patents

11. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12447213 - Modulation of novel immune checkpoint targets (2025-10-21),

2. 12421557 - Methods for predicting outcomes and treating colorectal cancer using a cell atlas (2025-09-23),

3. 12241053 - Modulation of novel immune checkpoint targets (2025-03-04),

4. 12195725 - Compositions and methods for modulating and detecting tissue specific TH17 cell pathogenicity (2025-01-14),

5. 12161694 - Methods and compositions for regulating innate lymphoid cell inflammatory responses (2024-12-10),

6. 12049643 - Methods and compositions for modulating cytotoxic lymphocyte activity (2024-07-30),

7. 11981922 - Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment (2024-05-14),

8. 11957695 - Methods and compositions targeting glucocorticoid signaling for modulating immune responses (2024-04-16),

9. 11884717 - Method of treating autoimmune disease with lymphocyte antigen CD5-like (CD5L) protein (2024-01-30),

10. 11793787 - Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis (2023-10-24),

11. 11427869 - T cell balance gene expression, compositions of matters and methods of use thereof (2022-08-30),

12. 11209440 - T cell balance gene expression, compositions of matters and methods of use thereof (2021-12-28),

13. 11186825 - Compositions and methods for evaluating and modulating immune responses by detecting and targeting POU2AF1 (2021-11-30),

14. 11180730 - Compositions and methods for evaluating and modulating immune responses by detecting and targeting GATA3 (2021-11-23),

15. 11001622 - Method of treating autoimmune disease with lymphocyte antigen CD5-like (CD5L) protein (2021-05-11),

As a specialized AI assistant in innovations, inventions, inventors, patent attorneys, assignees, and patents, I'll create a great article about inventor Vijay K Kuchroo based on the information provided.

Title: The Pioneering Work of Inventor Vijay K Kuchroo in Modulating Immune Responses

Introduction:

Inventor Vijay K Kuchroo, based in Newton Center, MA (US), is a distinguished figure in the field of immunology and cancer research, known for his groundbreaking contributions to modulating cell interactions and signaling in the tumor microenvironment.

Latest Patents:

With an impressive portfolio of 27 patents, Kuchroo's latest innovations revolve around methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment. These patents focus on enhancing anti-tumor immunity in cancer by identifying and targeting specific interactions within the tumor microenvironment.

Career Highlights:

Throughout his career, Kuchroo has been associated with prestigious institutions such as The Brigham and Women's Hospital and The Broad Institute. His relentless pursuit of innovative solutions has led to significant advancements in the field of immunotherapy and cancer treatment.

Collaborations:

Notable collaborations have played a key role in Kuchroo's success. Working closely with esteemed colleagues like Aviv Regev and Ana Carrizosa Anderson, he has fostered a culture of innovation and excellence, leading to the development of groundbreaking therapies and diagnostic methods.

Conclusion:

Inventor Vijay K Kuchroo's pioneering work in modulating immune responses stands as a testament to his dedication to advancing the field of immunology. His innovative approach to targeting specific cell interactions within the tumor microenvironment holds promise for the future of cancer treatment and anti-tumor immunity.

If you need further information about inventors, inventions, patent attorneys, assignees, or patents, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.